These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Niccoli G, Conte M, Marchitti S, Montone RA, Fracassi F, Grippo R, Roberto M, Burzotta F, Trani C, Leone AM, Bianchi F, Di Castro S, Volpe M, Crea F, Rubattu S. Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266 [Abstract] [Full Text] [Related]
3. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores. Schellings DA, Adiyaman A, Dambrink JE, Gosselink AM, Kedhi E, Roolvink V, Ottervanger JP, Van't Hof AW. Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547 [Abstract] [Full Text] [Related]
4. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome]. Liu WX, Zhao H. Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085 [Abstract] [Full Text] [Related]
13. Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Kurtul A, Duran M, Yarlioglues M, Murat SN, Demircelik MB, Ergun G, Acikgoz SK, Sensoy B, Cetin M, Ornek E. Clin Cardiol; 2014 Aug 01; 37(8):485-92. PubMed ID: 24805995 [Abstract] [Full Text] [Related]
14. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study. Ibrahim H, Sharma PK, Cohen DJ, Fonarow GC, Kaltenbach LA, Effron MB, Zettler ME, Peterson ED, Wang TY. J Am Heart Assoc; 2017 Oct 05; 6(10):. PubMed ID: 28982673 [Abstract] [Full Text] [Related]
15. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Goussot S, Mousson C, Guenancia C, Stamboul K, Brunel P, Brunet D, Touzery C, Cottin Y, Zeller M. Am J Cardiol; 2015 Sep 15; 116(6):865-71. PubMed ID: 26183794 [Abstract] [Full Text] [Related]
17. Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS. Farhan S, Clare RM, Jarai R, Giugliano RP, Lokhnygina Y, Harrington RA, Kristin Newby L, Huber K. Int J Cardiol; 2017 Apr 01; 232():264-270. PubMed ID: 28089149 [Abstract] [Full Text] [Related]
18. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, Barnathan ES, Califf R, Topol EJ, Simoons ML, Wallentin L. Circulation; 2003 Jul 22; 108(3):275-81. PubMed ID: 12847065 [Abstract] [Full Text] [Related]